RecruitingNot ApplicableNCT05494034

Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke.


Sponsor

National and Kapodistrian University of Athens

Enrollment

200 participants

Start Date

May 5, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

In this prospective cohort study, the investigators aim to investigate the incidence of ICM-detected AF in unselected ischemic stroke patients and its association with anticoagulation initiation and stroke recurrence.


Eligibility

Min Age: 40 YearsMax Age: 100 Years

Inclusion Criteria4

  • Consecutive acute ischemic stroke or TIA patients aged 40 years or older will be enrolled.
  • Diagnosis of acute ischemic stroke will be based on clinical and neuroimaging evaluation \[brain computed tomography (CT) scan or magnetic resonance imaging (MRI) scan\].
  • Stroke patients of all other etiologies (apart AF) presenting a HAVOC score ≥4 will be included in the study.
  • Informed consent for participation in the study will be obtained from the patients or guardians of patients.

Exclusion Criteria2

  • Patients with incomplete evaluation will be excluded, as previously described. \[22\] -Patients with known or newly detected AF at hospitalization will also be excluded.
  • Not providing informed consent.

Interventions

DEVICEReveal LINQTM

implantable cardiac monitoring device ("Reveal LINQTM")


Locations(1)

Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Athens, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05494034


Related Trials